BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 7702641)

  • 1. Cytotoxicity of 3'-azido-3'-deoxythymidine correlates with 3'-azidothymidine-5'-monophosphate (AZTMP) levels, whereas anti-human immunodeficiency virus (HIV) activity correlates with 3'-azidothymidine-5'-triphosphate (AZTTP) levels in cultured CEM T-lymphoblastoid cells.
    Törnevik Y; Ullman B; Balzarini J; Wahren B; Eriksson S
    Biochem Pharmacol; 1995 Mar; 49(6):829-37. PubMed ID: 7702641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracellular metabolism of CycloSaligenyl 3'-azido-2', 3'-dideoxythymidine monophosphate, a prodrug of 3'-azido-2', 3'-dideoxythymidine (zidovudine).
    Balzarini J; Naesens L; Aquaro S; Knispel T; Perno C; De Clercq E; Meier C
    Mol Pharmacol; 1999 Dec; 56(6):1354-61. PubMed ID: 10570065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacodynamic studies (PD) of didanosine (ddI) alone and in combination with azidothymidine (AZT) in human T-cells; a stochastic biochemical approach to antiretroviral nucleoside drug combination in inhibiting HIV-reverse transcriptase (RT).
    Periclou AP; Nandy P; Avramis VI
    In Vivo; 2000; 14(3):377-88. PubMed ID: 10904870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship of deoxynucleotide changes to inhibition of DNA synthesis induced by the antiretroviral agent 3'-azido-3'-deoxythymidine and release of its monophosphate by human lymphoid cells (CCRF-CEM).
    Fridland A; Connelly MC; Ashmun R
    Mol Pharmacol; 1990 May; 37(5):665-70. PubMed ID: 2338944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The M184V mutation reduces the selective excision of zidovudine 5'-monophosphate (AZTMP) by the reverse transcriptase of human immunodeficiency virus type 1.
    Boyer PL; Sarafianos SG; Arnold E; Hughes SH
    J Virol; 2002 Apr; 76(7):3248-56. PubMed ID: 11884549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence of in vitro development of drug resistance to azidothymidine in T-lymphocytic leukemia cell lines (Jurkat E6-1/AZT-100) and in pediatric patients with HIV-1 infection.
    Avramis VI; Kwock R; Solorzano MM; Gomperts E
    J Acquir Immune Defic Syndr (1988); 1993 Dec; 6(12):1287-96. PubMed ID: 8254464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2',3'-Dideoxycytidine toxicity in cultured human CEM T lymphoblasts: effects of combination with 3'-azido-3'-deoxythymidine and thymidine.
    Törnevik Y; Eriksson S
    Mol Pharmacol; 1990 Aug; 38(2):237-43. PubMed ID: 2166904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracellular metabolism of 3'-azidothymidine in isolated human peripheral blood mononuclear cells.
    Törnevik Y; Jacobsson B; Britton S; Eriksson S
    AIDS Res Hum Retroviruses; 1991 Sep; 7(9):751-9. PubMed ID: 1742082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced binding of azidothymidine-resistant human immunodeficiency virus 1 reverse transcriptase to the 3'-azido-3'-deoxythymidine 5'-monophosphate-terminated primer.
    Canard B; Sarfati SR; Richardson CC
    J Biol Chem; 1998 Jun; 273(23):14596-604. PubMed ID: 9603976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3'-Azido-3'-deoxythymidine-(5')-tetraphospho-(5')-adenosine, the product of ATP-mediated excision of chain-terminating AZTMP, is a potent chain-terminating substrate for HIV-1 reverse transcriptase.
    Dharmasena S; Pongracz Z; Arnold E; Sarafianos SG; Parniak MA
    Biochemistry; 2007 Jan; 46(3):828-36. PubMed ID: 17223704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pre-steady-state kinetic characterization of wild type and 3'-azido-3'-deoxythymidine (AZT) resistant human immunodeficiency virus type 1 reverse transcriptase: implication of RNA directed DNA polymerization in the mechanism of AZT resistance.
    Kerr SG; Anderson KS
    Biochemistry; 1997 Nov; 36(46):14064-70. PubMed ID: 9369478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3'-Azido-3'-deoxythymidine cytotoxicity and metabolism in the human colon tumor cell line HCT-8.
    Darnowski JW; Goulette FA
    Biochem Pharmacol; 1994 Nov; 48(9):1797-805. PubMed ID: 7980649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amino acid phosphoramidate monoesters of 3'-azido-3'-deoxythymidine: relationship between antiviral potency and intracellular metabolism.
    Chang S; Griesgraber GW; Southern PJ; Wagner CR
    J Med Chem; 2001 Jan; 44(2):223-31. PubMed ID: 11170632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitivity of HIV-1 reverse transcriptase and its mutants to inhibition by azidothymidine triphosphate.
    Carroll SS; Geib J; Olsen DB; Stahlhut M; Shafer JA; Kuo LC
    Biochemistry; 1994 Mar; 33(8):2113-20. PubMed ID: 7509634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphorylation of 3'-azido-3'-deoxythymidine and selective interaction of the 5'-triphosphate with human immunodeficiency virus reverse transcriptase.
    Furman PA; Fyfe JA; St Clair MH; Weinhold K; Rideout JL; Freeman GA; Lehrman SN; Bolognesi DP; Broder S; Mitsuya H
    Proc Natl Acad Sci U S A; 1986 Nov; 83(21):8333-7. PubMed ID: 2430286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and antiviral activity of 3'-azido-3'-deoxythymidine triphosphate distearoylglycerol: a novel phospholipid conjugate of the anti-HIV agent AZT.
    van Wijk GM; Hostetler KY; Kroneman E; Richman DD; Sridhar CN; Kumar R; van den Bosch H
    Chem Phys Lipids; 1994 Apr; 70(2):213-22. PubMed ID: 8033292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of beta-L-3'-azido-3'-deoxythymidine 5'-triphosphate on host and viral DNA polymerases.
    Faraj A; El Alaoui AM; Gosselin G; Imbach JL; Morrow C; Sommadossi JP
    Antiviral Res; 2000 Aug; 47(2):97-102. PubMed ID: 10996397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-nucleoside inhibitors of HIV-1 reverse transcriptase inhibit phosphorolysis and resensitize the 3'-azido-3'-deoxythymidine (AZT)-resistant polymerase to AZT-5'-triphosphate.
    Odriozola L; Cruchaga C; Andréola M; Dollé V; Nguyen CH; Tarrago-Litvak L; Pérez-Mediavilla A; Martínez-Irujo JJ
    J Biol Chem; 2003 Oct; 278(43):42710-6. PubMed ID: 12917424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human immunodeficiency virus reverse transcriptase. Substrate and inhibitor kinetics with thymidine 5'-triphosphate and 3'-azido-3'-deoxythymidine 5'-triphosphate.
    Reardon JE; Miller WH
    J Biol Chem; 1990 Nov; 265(33):20302-7. PubMed ID: 1700787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implication of the tRNA initiation step for human immunodeficiency virus type 1 reverse transcriptase in the mechanism of 3'-azido-3'-deoxythymidine (AZT) resistance.
    Vaccaro JA; Anderson KS
    Biochemistry; 1998 Oct; 37(40):14189-94. PubMed ID: 9760256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.